Dexamethasone in Hospitalized Patients with Covid-19

Cited by (1,035)

Items 201–300 of 1,035

1. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
   Sukrita Bhattacharjee, Mainak Banerjee · 2020 · SN Comprehensive Clinical Medicine
2. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
   German COVID-19 Omics Initiative (DeCOI), Aschenbrenner, Anna C., Mouktaroudi, Maria, Krämer, Benjamin, Oestreich, Marie, Antonakos, Nikolaos, Nuesch-Germano, Melanie, Gkizeli, Konstantina, Bonaguro, Lorenzo, Reusch, Nico et al. · 2021 · Genome Medicine
3. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
   Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot, Xavier Mariette A, Olivier Hermine, Matthieu Resche‐Rigon, Raphaël Porcher, Philippe Ravaud, Serge Bureau, Maxime Dougados et al. · 2021 · The Lancet Respiratory Medicine
4. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
   Syed Shahzad Hasan, Toby Capstick, Raees Ahmed, Chia Siang Kow, Faizan Mazhar, Hamid A. Merchant, Syed Tabish R. Zaidi · 2020 · Expert Review of Respiratory Medicine
5. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
   Lei Shi, Hai Huang, Xue-Chun Lu, Xiaoyan Yan, Xiaojing Jiang, Ruonan Xu, Siyu Wang, Chao Zhang, Xin Yuan, Zhe Xu et al. · 2021 · Signal Transduction and Targeted Therapy
6. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis
   Firoozeh V. Gerayeli, Stephen B Milne, Chung Yan Cheung, Xuan Li, Cheng Wei Tony Yang, Anthony Tam, Lauren H. Choi, Annie Bae, Don D. Sin · 2021 · EClinicalMedicine
7. Interleukin-6: obstacles to targeting a complex cytokine in critical illness
   Oliver J. McElvaney, Gerard F. Curley, Stefan Rose‐John, Noel Gerard McElvaney · 2021 · The Lancet Respiratory Medicine
8. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
   Ioannis P. Trougakos, Kimon S. Stamatelopoulos, Evangelos Terpos, Ourania Tsitsilonis, Evmorfia Aivalioti, Dimitrios N. Paraskevis, Efstathios Kastritis, George N. Pavlakis, Meletios Athanasios Dimopoulos · 2021 · Journal of Biomedical Science
9. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
   Noa Biran, Andrew Ip, Jaeil Ahn, Ronaldo Collo Go, Shuqi Wang, Shivam Mathura, Brittany Sinclaire, Urszula Bednarz, Michael Marafelias, Eric Hansen et al. · 2020 · The Lancet Rheumatology
10. COVID-19 and Cancer: Current Challenges and Perspectives
    Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, Solange Peters, Brian I. Rini, Jeremy Lyle Warner, Corrie Painter · 2020 · Cancer Cell
11. COVID-19: A review of therapeutic strategies and vaccine candidates
    Vladislav Izda, Matlock Arizona Jeffries, Amr H. Sawalha · 2020 · Clinical Immunology
12. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
    Sirui Zhou, Guillaume Butler‐Laporte, Tomoko Nakanishi, David Morrison, Jonathan Afilalo, Marc Afilalo, Laetitia Laurent, Maik Pietzner, Nicola D. Kerrison, Kaiqiong Zhao et al. · 2021 · Nature Medicine
13. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
    Zhila Maghbooli, Mohammad Ali Sahraian, Mehdi Ebrahimi, Marzieh Pazoki, Samira Kafan, Hedieh Moradi Tabriz, Azar Hadadi, Mahnaz Montazeri, Mehrad Nasiri, Arash Shirvani et al. · 2020 · PLoS ONE · Retracted
14. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
    Drucker, Daniel J. · 2021 · Cell Metabolism
15. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
    Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, Aisha Hegab Souquette, Daniel Reynolds, Diane E. Bender, James Percival Bosanquet, Nitin J. Anand, David A. Striker, R. Scott Martin et al. · 2020 · Science Advances
16. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
    Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M. et al. · 2021 · Nature Communications
17. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
    Andrew Bryant, Theresa Anne Lawrie, Therese Dowswell, Edmund J. Fordham, Scott A. Mitchell, Sarah Hill, Tony Tham · 2021 · American Journal of Therapeutics
18. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
    Mastellos, Dimitrios C., Pires da Silva, Bruno G.P., Fonseca, Benedito A.L., Fonseca, Natasha P., Auxiliadora-Martins, Maria, Mastaglio, Sara, Ruggeri, Annalisa, Sironi, Marina, Radermacher, Peter, Chrysanthopoulou, Akrivi et al. · 2020 · Clinical Immunology
19. Host-directed immunotherapy of viral and bacterial infections: past, present and future
    Robert S. Wallis, Anne O’Garra, Alan Sher, Andreas Wack · 2022 · Nature reviews. Immunology
20. Recent advances in regenerative biomaterials
    Dinglingge Cao, Jiandong Ding · 2022 · Regenerative Biomaterials
21. Impact of COVID-19 on the thyroid gland: an update
    Lorenzo Scappaticcio, Fabián Pitoia, Katherine Esposito, Arnoldo Piccardo, Pierpaolo Trimboli · 2020 · Reviews in Endocrine and Metabolic Disorders
22. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
    Dharma Rao Tompa, Aruldoss Immanuel, Srimari Srikanth, Kadhirvel Saraboji · 2021 · International Journal of Biological Macromolecules
23. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
    Jia-Xu Li, Carolyn L. Cummins · 2022 · Nature Reviews Endocrinology
24. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
    Xiangxiang Zeng, Xiang Hui Song, Tengfei Ma, Xiaoqin Pan, Yadi Zhou, Yuan Hou, Zheng Zhang, Kenli Li, George Karypis, Feixiong Cheng · 2020 · Journal of Proteome Research
25. Obesity: A critical risk factor in the COVID ‐19 pandemic
    See Kwok, Safwaan Adam, Jan Hoong Ho, Zohaib Iqbal, Peter M Turkington, Salman Razvi, Carel Wynand le Roux, Handrean Soran, Akheel A. Syed · 2020 · Clinical Obesity
26. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19
    Sarthak Sinha, Nicole L. Rosin, Rohit Arora, Elodie Labit, Arzina Jaffer, Leslie Cao, Raquel Farias, Angela Nguyen, Luiz Gustavo Nogueira de Almeida, Antoine Dufour et al. · 2021 · Nature Medicine
27. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases
    Rita M. Meganck, Ralph Steven Baric · 2021 · Nature Medicine
28. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia
    The COVID STEROID 2 Trial Group, Lene Russell, Kis Rønn Uhre, Ann Louise Syraach Lindgaard, Jette Fredlund Degn, Mik Wetterslev, Praleene Sivapalan, Carl Thomas Anthon, Vibe Sommer Mikkelsen, Louise Colette la Porta et al. · 2021 · JAMA
29. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
    Awadhesh Kumar Singh, Sujoy Majumdar, Ritu Singh, Anoop Misra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
30. Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
    Maria Isabel Fernandes Lopes, Letícia Pastorelli Bonjorno, Marcela C Giannini, Natália B. do Amaral, Pamella Indira Menezes, SAULO MUSSE DIB, SAMARA LIBICH GUSMÃO GIGANTE, Maíra Nilson Benatti, Uebe C Rezek, Laerte L Emrich-Filho et al. · 2021 · RMD Open
31. Neutrophils in COVID-19
    Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Kevin E. Bassler, Joachim Ludwig Schultze, Anna C. Aschenbrenner · 2021 · Frontiers in Immunology
32. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): A randomised, double-blind, placebo-controlled, phase 3 trial
    Kosiborod, Mikhail N, Esterline, Russell, Furtado, Remo H M, Oscarsson, Jan, Gasparyan, Samvel B, Koch, Gary G, Martinez, Felipe, Mukhtar, Omar, Verma, Subodh, Chopra, Vijay et al. · 2021 · The Lancet Diabetes & Endocrinology
33. Host genetics and infectious disease: new tools, insights and translational opportunities
    Andrew John Kwok, Alexander J. Mentzer, Julian Charles Knight · 2020 · Nature Reviews Genetics
34. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
    Min Seo Kim, Min Ho An, Won Jun Kim, Tae-Ho Hwang · 2020 · PLoS Medicine
35. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
    François-Xavier Lescure, Hitoshi Honda, Robert Fowler, Jennifer Sloane Lazar, Genming Shi, Peter K. Wung, Naimish R. Patel, OWEN R. HAGINO, Ignacio J. Bazzalo, Marcelo Martín Casas et al. · 2021 · The Lancet Respiratory Medicine
36. COVID-19 and metabolic disease: mechanisms and clinical management
    Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, Andreas Linkermann, Paul Zimmet, Konstantin Yu. Kulebyakin, Tkachuk Va, Alexander Georgievich Markov, Hendrik Lehnert, Martin Hrabě de Angelis et al. · 2021 · The Lancet Diabetes & Endocrinology
37. Innate immune evasion strategies of SARS-CoV-2
    Judith M. Minkoff, Benjamin Robert tenOever · 2023 · Nature Reviews Microbiology
38. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia
    Dipayan Chaudhuri, Andrea M. Nei, Bram N. Rochwerg, ROBERT A. BALK, Karim Asehnoune, Rhonda S. Cadena, Joseph A. Carcillo, Ricardo Correa, Katherine Drover, Annette M. Esper et al. · 2024 · Critical Care Medicine
39. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection
    Desai, Niyati, Neyaz, Azfar, Szabolcs, Annamaria, Shih, Angela R., Chen, Jonathan H., Thapar, Vishal, Nieman, Linda T., Solovyov, Alexander, Mehta, Arnav, Lieb, David J. et al. · 2020 · Nature Communications
40. Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic
    David A. Asch, Natalie E. Sheils, Md Nazmul Islam, Yong Chen, Rachel M. Werner, John Buresh, Jalpa A. Doshi · 2020 · JAMA Internal Medicine
41. Azithromycin in the treatment of COVID-19: a review
    Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, Marta de Antonio-Cuscó, Olivia Ferrández, Juan Pablo Horcajada, Santiago Grau · 2020 · Expert Review of Anti-infective Therapy
42. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
    Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh, Mohammad Javad Fallahi, Vahid Khaloo, Reza Shahriarirad, Amirhossein Erfani, Zohre Khodamoradi, Mohammad Hasan Gholampoor Saadi · 2021 · BMC Infectious Diseases
43. Long COVID: pathophysiological factors and abnormalities of coagulation
    Simone Turner, Asad Khan, David F. Putrino, Ashley A. Woodcock, Douglas Bruce Kell, Etheresia Pretorius · 2023 · Trends in Endocrinology and Metabolism
44. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
    Luke Y. C. Chen, Ryan L. Hoiland, Sophie K. Stukas, Cheryl Lea Wellington, Mypinder S. Sekhon · 2020 · European Respiratory Journal
45. Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training – A review
    Catrin Sohrabi, Ginimol Mathew, Thomas Franchi, Ahmed Kerwan, Michelle Griffin, Jennick Soleil C Del Mundo, Syed Ahsan Ali, Maliha Agha, Riaz Agha · 2021 · International Journal of Surgery
46. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
    Perrine Janiaud, Cathrine Axfors, Andreas Michael Schmitt, Viktoria Gloy, Fahim Ebrahimi, Matthias Hepprich, Emily Rose Smith, Noah Haber, Nina Khanna, David Moher et al. · 2021 · JAMA
47. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
    Sparks, Jeffrey A, Wallace, Zachary S, Seet, Andrea M, Gianfrancesco, Milena A, Izadi, Zara, Hyrich, Kimme L, Strangfeld, Anja, Gossec, Laure, Carmona, Loreto, Mateus, Elsa F et al. · 2021 · Annals of the Rheumatic Diseases
48. The development of COVID-19 treatment
    Yongliang Yuan, Baihai Jiao, Lili Qu, Duomeng Yang, Ruijuan Liu · 2023 · Frontiers in Immunology
49. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
    Sara Cajander, Matthijs Kox, Brendon P. Scicluna, Markus Alexander Weigand, Raquel Almansa Mora, Stefanie B. Flohé, Ignacio Martín‐Loeches, Gunnar Lachmann, Massimo Girardis, Alberto García‐Salido et al. · 2023 · The Lancet Respiratory Medicine
50. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
    Christopher T. Rentsch, Joshua A. Beckman, Laurie A. Tomlinson, Walid F. Gellad, Charles Alcorn, Farah Kidwai‐Khan, Melissa Skanderson, Evan L. Brittain, Joseph T. King, Yuk-Lam Anne Ho et al. · 2021 · BMJ
51. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
    Jordan J. Feld, Christopher E. Kandel, Mia J. Biondi, Robert Andrew Kozak, Muhammad Atif Zahoor, Camille Lemieux, Sergio M. Borgia, Andrea K. Boggild, Jeff E. Powis, Janine McCready et al. · 2021 · The Lancet Respiratory Medicine
52. Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis
    Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar · 2020 · European Journal of Clinical Investigation
53. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
    Liam Gaziano, Claudia Giambartolomei, Alexandre C. Pereira, Anna Gaulton, Daniel C. Posner, Sonja Alsemgeest Swanson, Yuk-Lam Anne Ho, Sudha K. Iyengar, Nicole Kosik, Marijana Vujković et al. · 2021 · Nature Medicine
54. Genetic mechanisms of critical illness in Covid-19
    Erola Pairo‐Castineira, Sara Clohisey, Lucija Klarić, Andrew D. Bretherick, Konrad Rawlik, Nick Parkinson, Dorota Pasko, Susan Walker, Anne Richmond, Max Head Fourman et al. · 2020 · medRxiv
55. Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
    Mukhtar H. Ahmed, Arez Hassan · 2020 · SN Comprehensive Clinical Medicine
56. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
    Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins, Felicity Liew, Clark D Russell, Shona C. Moore, Cameron J. Fairfield, Edwin Carter, Simon Timothy Abrams, Charlotte-Eve S. Short et al. · 2021 · Science Immunology
57. Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020
    Dennis, John M., McGovern, Andrew P., Vollmer, Sebastian J., Mateen, Bilal A. · 2021 · Critical Care Medicine
58. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
    Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, Jon Salmanton‐García, Johan A. Maertens, Marc Bourgeois, Marijke Reynders, Lynn Rutsaert, Niels Van Regenmortel, Piet Lormans et al. · 2021 · Clinical Microbiology and Infection
59. Resolution of coronavirus disease 2019 (COVID-19)
    Khaled Habas, Chinyere Chioma Nganwuchu, Fanila Shahzad, Rajendran C. Gopalan, Mainul Haque, Sayeeda Rahman, Md Anwarul Azim Majumder, Talat Nasim · 2020 · Expert Review of Anti-infective Therapy
60. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
    Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, Benjamin Amor, Adit Anand, Mark M. Bissell, Katie R. Bradwell, Carolyn Bremer, James Brian Byrd, Alina Denham et al. · 2021 · JAMA Network Open
61. COVID-19 in cancer patients: risk, clinical features, and management
    Cuiwei Liu, Yanxia Zhao, Derick K. Okwan-Duodu, Reva Kakkar Basho, Xiaojiang Cui · 2020 · Cancer Biology and Medicine
62. Preliminary predictive criteria for COVID-19 cytokine storm
    Caricchio, Roberto, Gallucci, Marcello, Dass, Chandra, Zhang, Xinyan, Gallucci, Stefania, Fleece, David, Bromberg, Michael, Criner, Gerard J · 2021 · Annals of the Rheumatic Diseases
63. Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
    Eric Salazar, Paul A. Christensen, Edward A. Graviss, Duc T. Nguyen, Brian Castillo, Jian Chen, Bevin V. Lopez, Todd N. Eagar, Xin Yi, Picheng Zhao et al. · 2020 · American Journal Of Pathology
64. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
    Ankit Bharat, Tiago Machuca, Melissa Querrey, Chitaru Kurihara, Rafael Garza‐Castillon, Samuel Kim, Adwaiy Jayant Manerikar, Andrés Peláez, Maurício Pipkin, Abbas Shahmohammadi et al. · 2021 · The Lancet Respiratory Medicine
65. Trends in COVID-19 risk-adjusted mortality rates
    Horwitz, Leora I, Jones, Simon A, Cerfolio, Robert J, Francois, Fritz, Greco, Joseph, Rudy, Bret, Petrilli, Christopher M · 2021 · Journal of Hospital Medicine
66. Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis
    Ammirati, Enrico, Lupi, Laura, Palazzini, Matteo, Hendren, Nicholas S., Grodin, Justin L., Cannistraci, Carlo V., Schmidt, Matthieu, Hekimian, Guillaume, Peretto, Giovanni, Bochaton, Thomas et al. · 2022 · Circulation
67. Environmental effects of stratospheric ozone depletion, UV radiation, and interactions with climate change: UNEP Environmental Effects Assessment Panel, Update 2020
    Neale, R. E., Barnes, P. W., Robson, T. M., Neale, P. J., Williamson, C. E., Zepp, R. G., Wilson, S. R., Madronich, S., Andrady, A. L., Heikkilä, A. M. et al. · 2021 · Photochemical & Photobiological Sciences
68. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
    Joan T. Merrill, Doruk Erkan, Jerald Winakur, Judith A. James · 2020 · Nature Reviews Rheumatology
69. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
    Arvinder Singh Soin, Kuldeep Kumar, Narendra Singh Choudhary, Pooja Sharma, Yatin B. Mehta, Sushila Kataria, Deepak Govil, Vikas Deswal, Dhruva Chaudhry, Pawan Kumar Singh et al. · 2021 · The Lancet Respiratory Medicine
70. Cognitive impact of COVID-19: looking beyond the short term
    James Scott Miners, Patrick G. Kehoe, Seth Love · 2020 · Alzheimer s Research & Therapy
71. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
    Richard J. Mills, Sean J. Humphrey, Patrick R.J. Fortuna, Mary Lor, Simon Richard Foster, Gregory A. Quaife-Ryan, Rebecca L. Johnston, Troy D. Dumenil, Cameron Bishop, Rajeev Rudraraju et al. · 2021 · Cell
72. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19
    Matthew Charles Woodruff, Richard Paul Ramonell, Natalie S. Haddad, Fabliha A. Anam, Mark E. Rudolph, Tiffany A. Walker, Alexander D. Truong, Adviteeya N. Dixit, Jenny E. Han, Monica Cabrera-Mora et al. · 2022 · Nature
73. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
    Jim Baggen, Leentje Persoons, Els Vanstreels, Sander Jansen, Dominique Van Looveren, Bram Boeckx, Vincent Geudens, Julie De Man, Dirk Jochmans, Joost Wauters et al. · 2021 · Nature Genetics
74. A time-resolved proteomic and prognostic map of COVID-19
    Demichev, Vadim, Tober-Lau, Pinkus, Lemke, Oliver, Nazarenko, Tatiana, Thibeault, Charlotte, Whitwell, Harry, Röhl, Annika, Freiwald, Anja, Szyrwiel, Lukasz, Ludwig, Daniela et al. · 2021 · Cell Systems
75. Vaccines for COVID-19
    John S. Tregoning, E S Brown, Hannah M. Cheeseman, Katie E. Flight, Sophie L. Higham, N-M Lemm, Benjamin F. Pierce, David C. Stirling, Ziyin Wang, Katrina M. Pollock · 2020 · Clinical & Experimental Immunology
76. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
    Gianfranco Umberto Meduri, Mei‐Chiung Shih, Lisa Bridges, Thomas J. Martin, Ali El-Solh, Nitin Seam, Anne Davis‐Karim, Reba A. Umberger, Antonio Anzueto, Peruvemba Sriram et al. · 2022 · Intensive Care Medicine
77. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
    John, Alison E., Joseph, Chitra, Jenkins, Gisli, Tatler, Amanda L. · 2021 · Immunological Reviews
78. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
    James Duncan Chalmers, Megan Louise Crichton, Pieter Goeminne, Bin Cao, Marc J.C. Humbert, Michal Shteinberg, Katerina M. Antoniou, Charlotte Suppli Ulrik, Helen Parks, Chen Wang et al. · 2021 · European Respiratory Journal
79. How COVID-19 has fundamentally changed clinical research in global health
    Jay Park, Robin Mogg, Gerald E Smith, Etheldreda Nakimuli‐Mpungu, Fyezah Jehan, Craig R. Rayner, Jeanine Umutesi Condo, Eric H. Decloedt, Jean Bisimwa Nachega, Gilmar Reis et al. · 2021 · The Lancet Global Health
80. Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
    Writing Committee for the REMAP-CAP Investigators, Abdelhady, Hesham, Abdelrazik, Marwa, Abdi, Zakee, Abdo, David, Abdulle, Amina, Abel, Lynn, Abouzeenni, Shrefee, Abrahamson, Gail, Abusamra, Yousuf et al. · 2021 · JAMA
81. Bacterial Coinfections in Coronavirus Disease 2019
    Lars F. Westblade, Matthew S. Simon, Michael J. Satlin · 2021 · Trends in Microbiology
82. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
    Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D. Lau, Luis G. Gómez-Escobar, Lunkun Ma, Ankit Gilani, Sergio L. Alvarez-Mulett, Evan Sholle, Vasuretha Chandar et al. · 2021 · Cell Metabolism
83. The intersection of COVID-19 and autoimmunity
    Jason S. Knight, Roberto Caricchio, Jean‐Laurent Casanova, Alexis J. Combes, Betty Diamond, Sharon E. Fox, David A. Hanauer, Judith A. James, Yogendra M. Kanthi, Virginia Ladd et al. · 2021 · Journal of Clinical Investigation
84. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
    Lars F. Westblade, Gagandeep Singh Brar, Laura C. Pinheiro, Demetrios Paidoussis, Mangala Rajan, Peter Martin, Parag Goyal, Jorge L. Sepulveda, Lisa Zhang, Gary George et al. · 2020 · Cancer Cell
85. Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
    Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, Audrey E. Fischer, Matthew J. O’Meara, Blandine Monel, Thomas Vallet, Kris M. White, Ziyang Zhang, Assaf Alon et al. · 2021 · Science
86. Phenotypes and personalized medicine in the acute respiratory distress syndrome
    Michael A. Matthay, Yaseen M. Arabi, Emily R. Siegel, Lorraine B. Ware, Lieuwe D. J. Bos, Pratik Sinha, Jeremy R. Beitler, Katherine D. Wick, Martha A. Q. Curley, Jean‐Michel Constantin et al. · 2020 · Intensive Care Medicine
87. Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study
    Stanislas Grassin‐Delyle, Camille Roquencourt, Pierre Moine, Gabriel Saffroy, Stanislas Carn, Nicholas Heming, Jérôme Fleuriet, Hélène Salvator, Emmanuel Naline, Louis‐Jean Couderc et al. · 2020 · EBioMedicine
88. Accelerating antiviral drug discovery: lessons from COVID-19
    Annette von Delft, Matthew D. Hall, Ann D. Kwong, Lisa A. Purcell, Kumar Singh Saikatendu, Uli Schmitz, John A. Tallarico, Alpha A. Lee · 2023 · Nature Reviews Drug Discovery
89. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
    Patrícia Figueiredo‐Campos, Birte Blankenhaus, Catarina Mota, Andréia Gomes, Marta Serrano, Silvia Ariotti, Catarina Januária Mendes da Costa, Helena Nunes‐Cabaço, António M. Mendes, Pedro Gaspar et al. · 2020 · European Journal of Immunology
90. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19
    Jesus Alvarez Garcia, Samuel J. Lee, Arjun Gupta, Matthew Cagliostro, Aditya A. Joshi, Mercedes Rivas‐Lasarte, Johanna Contreras, Sumeet Singh Mitter, Gina LaRocca, Pilar Tlachi et al. · 2020 · Journal of the American College of Cardiology
91. Methylprednisolone in adults hospitalized with COVID-19 pneumonia
    Luís Corral-Gudino, Alberto Bahamonde, Francisco Arnaiz-Revillas, Julia Gómez Barquero, Jesica Abadía-Otero, Carmen García‐Ibarbia, Victor Mora, Ana Cerezo-Hernández, Ana Cerezo-Hernández, Graciela López-Muñíz et al. · 2021 · Wiener klinische Wochenschrift
92. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
    RECOVERY Collaborative Group, Peter W Horby, Mark Campbell, Enti Spata, Jonathan Emberson, Natalie Staplin, Guilherme Pessoa-Amorim, Leon Peto, Martin Wiselka, Laura Wiffen et al. · 2021 · The Lancet Respiratory Medicine
93. Long term respiratory complications of covid-19
    Emily Fraser · 2020 · BMJ
94. CT of Post-Acute Lung Complications of COVID-19
    Solomon, Joshua J., Heyman, Brooke, Ko, Jane P., Condos, Rany, Lynch, David A. · 2021 · Radiology
95. Advancing precision medicine for acute respiratory distress syndrome
    Jeremy R. Beitler, Bruce Thompson, Rebecca M Baron, Julie A Bastarache, Loren C Denlinger, Laura J. Esserman, Michelle N Gong, Lisa Morrissey LaVange, Roger J. Lewis, John C Marshall et al. · 2021 · The Lancet Respiratory Medicine
96. The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
    José Laerte Boechat, Inês Chora, António Morais, Luís Delgado · 2021 · Pulmonology
97. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
    Rishi K Gupta, Ewen Munro Harrison, Antonia Ying Wai Ho, Annemarie Beth Docherty, Stephen Richard Knight, Maarten van Smeden, Ibrahim Abubakar, Marc C.I. Lipman, Matteo Quartagno, Riinu Pius et al. · 2021 · The Lancet Respiratory Medicine
98. Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020
    Sameer S. Kadri, Junfeng Sun, Alexander Lawandi, Jeffrey R. Strich, Lindsay M. Busch, Michael Keller, Ahmed Babiker, Christina Yek, Seidu Malik, Janell Krack et al. · 2021 · Annals of Internal Medicine
99. Pathogenesis and treatment of cytokine storm in COVID-19
    Mehmet Soy, Gökhan Keser, Pamir Atagündüz · 2021 · TURKISH JOURNAL OF BIOLOGY
100. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
     Daniel Chauss, Tilo Freiwald, Reuben McGregor, Bingyu Yan, Luopin Wang, Estefanía Nova‐Lamperti, Dhaneshwar Kumar, Zonghao Zhang, Heather Teague, Erin E. West et al. · 2021 · Nature Immunology